Cargando…

Can changing the prodrug moiety in remdesivir be a life-saving strategy in COVID-19 infection?

Detalles Bibliográficos
Autores principales:	Prabha, Praisy K., Prakash, Ajay, Medhi, Bikash
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2023
Materias:	Practice: Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10284358/ https://www.ncbi.nlm.nih.gov/pubmed/37040235 http://dx.doi.org/10.4103/ijmr.ijmr_233_22

Ejemplares similares

Clinical trials for food – The gray areas: Developing countries' perspective
por: Prabha, Praisy K., et al.
Publicado: (2023)

Monkeypox infection: A quick glance
por: Choudhary, Gajendra, et al.
Publicado: (2022)

Efficacy and safety of inhaled nitric oxide in the treatment of severe/critical COVID-19 patients: A systematic review
por: Prakash, Ajay, et al.
Publicado: (2021)

Update on omicron variant: What we know so far
por: Choudhary, Gajendra, et al.
Publicado: (2022)

Pro-Moieties of Antimicrobial Peptide Prodrugs
por: Forde, Eanna, et al.
Publicado: (2015)

Remdesivir for patients with COVID-19
por: Wu, Peter E., et al.
Publicado: (2021)

Metabolic Efficacy of Phosphate Prodrugs and the Remdesivir Paradigm
por: Wiemer, Andrew J.
Publicado: (2020)

Postmarketing pharmacovigilance: Remdesivir and cardiovascular events
por: Sullivan, John T.
Publicado: (2022)

Can the One Health Approach Save Us from the Emergence and Reemergence of Infectious Pathogens in the Era of Climate Change: Implications for Antimicrobial Resistance?
por: Gudipati, Smitha, et al.
Publicado: (2020)

Baricitinib + remdesivir cost saving vs remdesivir for hospitalised COVID-19 patients in the USA
Publicado: (2021)

Placing the results of the SOLIDARITY trial with regards to remdesivir in perspective
por: Bose, Debdipta, et al.
Publicado: (2021)

What Do We Know About Remdesivir Drug Interactions?
por: Yang, Katherine
Publicado: (2020)

New Perspectives on Antimicrobial Agents: Remdesivir Treatment for COVID-19
por: Aleissa, Muneerah M., et al.
Publicado: (2020)

Should remdesivir be recommended in France in the early stage of COVID-19
por: Martin, Martinot
Publicado: (2022)

Rethinking Remdesivir: Synthesis, Antiviral Activity and Pharmacokinetics of Oral Lipid Prodrugs
por: Schooley, Robert T., et al.
Publicado: (2021)

Rethinking Remdesivir: Synthesis, Antiviral Activity, and Pharmacokinetics of Oral Lipid Prodrugs
por: Schooley, Robert T., et al.
Publicado: (2021)

Bradycardia associated with remdesivir therapy for COVID-19 in a 59-year-old man
por: Day, Leora Branfield, et al.
Publicado: (2021)

Pharmacokinetics of Temsavir, the Active Moiety of the Prodrug Fostemsavir, in Subjects with Hepatic Impairment
por: Sevinsky, Heather, et al.
Publicado: (2017)

Xylitol as a Hydrophilization Moiety for a Biocatalytically Synthesized Ibuprofen Prodrug
por: Zappaterra, Federico, et al.
Publicado: (2022)

Optimal management of drug-resistant tuberculosis: Can India lead the way?
por: Masini, Tiziana, et al.
Publicado: (2023)

Saving sight in China and beyond: the Lifeline Express model
por: Wong, Ian Yat Hin, et al.
Publicado: (2018)

Remdesivir saves lives. Were 3 years needed to learn that?
por: Kalil, Andre C
Publicado: (2023)

A Day in the Life of a British General Practitioner
por: Swain, Sahadev
Publicado: (2013)

The nucleoside antiviral prodrug remdesivir in treating COVID-19 and beyond with interspecies significance
por: Yan, Daisy, et al.
Publicado: (2021)

Synthetic strategies for pyrrolo[2,1-f][1,2,4]triazine: the parent moiety of antiviral drug remdesivir
por: Rai, Gaurav S., et al.
Publicado: (2021)

Remdesivir: Remedy the world is waiting for?
por: Suranagi, Umesh Devappa, et al.
Publicado: (2020)

Save the planet with green industries using algae
por: Ralph, Peter J., et al.
Publicado: (2023)

Granulocyte-colony stimulating factor improves Parkinson's disease associated with co-morbid depression: An experimental exploratory study
por: Prakash, Ajay, et al.
Publicado: (2013)

New generation vaccine: Novel approaches of vaccine design and delivery and current challenges of vaccine development
por: Bansal, Seema, et al.
Publicado: (2022)

Imaging techniques in drug development
por: Gupta, Shreya, et al.
Publicado: (2022)

Do alternatives to animal experimentation replace preclinical research?
por: Mahalmani, Vidya, et al.
Publicado: (2023)

‘What is Inconvenient for You is Life-saving for Me’: How Health Inequities are playing out during the COVID-19 Pandemic
por: Xafis, Vicki
Publicado: (2020)

Caution About Truncation-By-Death in Clinical Trial Statistical Analysis: A Lesson from Remdesivir
por: Deng, Yuhao, et al.
Publicado: (2021)

Temporary Alternative Screening Strategy for Gestational Diabetes Screening During the COVID-19 Pandemic—The Need for a Middle Ground
por: Yamamoto, Jennifer M., et al.
Publicado: (2022)

In vitro evaluation of the impact of Covid-19 therapeutic agents on the hydrolysis of the antiviral prodrug remdesivir
por: Zhang, Qingchen, et al.
Publicado: (2022)

Saving Lives in Health: Global Estimates and Country Measurement
por: Low-Beer, Daniel, et al.
Publicado: (2013)

Is cord blood worth saving for public or private banking?
por: Lee, Young-Ho
Publicado: (2015)

Radiation-induced prodrug activation: extending combined modality therapy for some solid tumours
por: Farrer, Nicola J., et al.
Publicado: (2022)

Remdesivir may be cost saving in eligible patients during COVID-19 infections in Germany
Publicado: (2021)

An urgent need for experimental animal model of autism in drug development
por: Ruhela, Rakesh K, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ia4bnsukso3vh11kjtj4g0cumm